US Patent Issued to Denali Therapeutics on Aug. 11 for "Anti-HER2 antibodies and methods of use thereof" (California, New York Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,761, issued on Aug. 11, was assigned to Denali Therapeutics Inc. (South San Francisco, Calif.).

"Anti-HER2 antibodies and methods of use thereof" was invented by Abira Bandyopadhyay (Pleasanton, Calif.), Allisa Jayne Clemens (San Jose, Calif.), Do Jin Kim (Albany, N.Y.), Michelle E. Pizzo (Pacifica, Calif.), Lu Shan (Belmont, Calif.), Richard Theolis Jr. (Santa Cruz, Calif.) and Raymond Ka Hang Tong (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In one aspect, antibodies that bind to subdomain II of human HER2 are provided. In another aspect, antibodies comprising a light chain polypeptide that pairs with both a heavy ch...